We serve Chemical Name:strontium zirconate CAS:12036-39-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:strontium zirconate
CAS.NO:12036-39-4
Synonyms:strontium,dioxido(oxo)zirconium;Strontium zirconium oxide;MFCD00049555;Strontium zirconate;EINECS 234-847-4
Molecular Formula:O3SrZr
Molecular Weight:226.84200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:5.46 g/cm3
Index of Refraction:2.08
PSA:63.19000
Exact Mass:225.79500
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like strontium,dioxido(oxo)zirconium chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 234-847-4 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,strontium,dioxido(oxo)zirconium Use and application,strontium,dioxido(oxo)zirconium technical grade,usp/ep/jp grade.
Related News: J&J’s shot generates roughly 8 GBS cases per million vaccinated people, far higher than just a single case reported per million among mRNA recipients, CDC reported. (1,1,1-trifluoro-2-hydroxy-3-methoxy-3-oxopropan-2-yl)phosphonic acid manufacturers The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems. 2-Hydrazinonicotinic acid suppliers J&J’s shot generates roughly 8 GBS cases per million vaccinated people, far higher than just a single case reported per million among mRNA recipients, CDC reported. 7-Methoxybenzofuran vendor & factory A CDMO must have bolt-on capabilities with efficient chemistry which translates into adding new capabilities that the specific molecule development may require quickly. ,These companies need cost-effective, seamless ways to move small molecule compounds from early-phase to commercial according to global quality and regulatory standards, and these expanded facilities at our Nansha site are designed to help them to do so.”
